• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.33% Nasdaq Down 0.35%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    2.17 Down 0.03(1.36%) 1:58PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.20
    Open:2.19
    Bid:2.17 x 7400
    Ask:2.18 x 5500
    1y Target Est:8.80
    Beta:2.9
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:2.13 - 2.22
    52wk Range:1.85 - 4.97
    Volume:1,110,689
    Avg Vol (3m):1,535,330
    Market Cap:291.69M
    P/E (ttm):N/A
    EPS (ttm):-0.80
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SNTADown 1.36%291.69M
    INFIUp 3.19%522.79M
    NVSUp 0.89%240.58B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.74
    Quarterly EPS Est (Jun-15) :-0.18
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback